Cargando…
Peripheral transcriptomic biomarkers for early detection of sporadic Alzheimer disease?
Alzheimer disease (AD) is the major epidemic of the 21(st) century, its prevalence rising along with improved human longevity. Early AD diagnosis is key to successful treatment, as currently available therapeutics only allow small benefits for diagnosed AD patients. By contrast, future therapeutics,...
Autores principales: | Hadar, Adva, Gurwitz, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Les Laboratoires Servier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6436957/ https://www.ncbi.nlm.nih.gov/pubmed/30936769 |
Ejemplares similares
-
Early detection of Alzheimer's disease: new diagnostic criteria
por: Dubois, Bruno, et al.
Publicado: (2009) -
Biological markers for early detection and pharmacological treatment of Alzheimer's disease
por: Hampel, Harald, et al.
Publicado: (2009) -
Transcriptomic profiling of sporadic Alzheimer’s disease patients
por: Caldwell, Andrew B., et al.
Publicado: (2022) -
Genetic Variants and Related Biomarkers in Sporadic Alzheimer’s Disease
por: Guerreiro, Rita, et al.
Publicado: (2014) -
Ligature of Left Carotid Artery for Hemorrhage Following Kiotomy
por: Liden, Hadar, et al.
Publicado: (1880)